Literature DB >> 17585007

Extrinsic goals and time tradeoff.

Marjon van der Pol1, Alan Shiell.   

Abstract

BACKGROUND: The aim of this article is to investigate the extrinsic goals hypothesis in time tradeoff (TTO). The extrinsic goal of interest here is seeing children through to maturity. In TTO, the time it takes to attain this goal becomes a target life expectancy, with no trades happening below the critical value implied by the target, no matter how severe the health state.
METHODS: A combined quantitative and qualitative approach was used to elicit values for 4 EQ-5D states from 30 recent mothers. The qualitative analysis allowed the researchers to explore with participants whether a target life expectancy was being used.
RESULTS: The differences in the visual analogue scale and TTO scores of the mothers compared with the general population suggest that the mothers value life-years differently than the general population does. The finding was also consistent with the target life expectancy hypothesis. However, the interview data were not so strongly supportive of the target life expectancy hypothesis. Although some women suggested this had motivated their responses to the TTO, the interviews paint a more complicated and nuanced picture of what drives a person's responses to health valuation surveys.
CONCLUSIONS: A higher value was assigned to life-years relative to quality of life by recent parents, but there was no reduction in the willingness to trade per se. Parenthood affects how much one will trade for better health but not whether one will trade in the 1st place. This conclusion became apparent only when the qualitative and quantitative data were combined.

Entities:  

Mesh:

Year:  2007        PMID: 17585007     DOI: 10.1177/0272989X07302127

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  9 in total

1.  Thirty down, only ten to go?! Awareness and influence of a 10-year time frame in TTO.

Authors:  F E van Nooten; X Koolman; J J V Busschbach; W B F Brouwer
Journal:  Qual Life Res       Date:  2013-08-14       Impact factor: 4.147

2.  Measuring health utility in varying pregnancy contexts among a diverse cohort of pregnant women.

Authors:  Lisbet S Lundsberg; Xiao Xu; Eleanor B Schwarz; Aileen M Gariepy
Journal:  Contraception       Date:  2017-08-17       Impact factor: 3.375

3.  What should we know about the person behind a TTO?

Authors:  Floortje van Nooten; Jan Busschbach; Michel van Agthoven; Job van Exel; Werner Brouwer
Journal:  Eur J Health Econ       Date:  2018-12

4.  Measuring the effects of unintended pregnancy on women's quality of life.

Authors:  Eleanor Bimla Schwarz; Rachel Smith; Jody Steinauer; Matthew F Reeves; Aaron B Caughey
Journal:  Contraception       Date:  2008-07-22       Impact factor: 3.375

5.  "Married with children" the influence of significant others in TTO exercises.

Authors:  F E van Nooten; N J A van Exel; X Koolman; W B F Brouwer
Journal:  Health Qual Life Outcomes       Date:  2015-07-02       Impact factor: 3.186

6.  Impact of caregiver and parenting status on time trade-off and standard gamble utility scores for health state descriptions.

Authors:  Louis S Matza; Kristina S Boye; David H Feeny; Joseph A Johnston; Lee Bowman; Jessica B Jordan
Journal:  Health Qual Life Outcomes       Date:  2014-04-09       Impact factor: 3.186

7.  Are preferences over health states informed?

Authors:  M Karimi; J Brazier; S Paisley
Journal:  Health Qual Life Outcomes       Date:  2017-05-18       Impact factor: 3.186

8.  Time trade-off with someone to live for: impact of having significant others on time trade-off valuations of hypothetical health states.

Authors:  Tonya Moen Hansen; Knut Stavem; Kim Rand
Journal:  Qual Life Res       Date:  2021-10-30       Impact factor: 3.440

9.  Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol.

Authors:  Tonya Moen Hansen; Ylva Helland; Liv Ariane Augestad; Kim Rand; Knut Stavem; Andrew Garratt
Journal:  BMJ Open       Date:  2020-06-11       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.